Control of messenger RNA (mRNA) stability is an important aspect of gene regulation. The gold standard for measuring mRNA stability transcriptome-wide uses metabolic labeling, biochemical isolation of labeled RNA populations, and high-throughput sequencing. However, difficult normalization procedures and complex computational algorithms have inhibited widespread adoption of this approach. Here, we present DRUID (for Determination of Rates Using Intron Dynamics), a computational pipeline that is robust, easy to use, and freely available. Our pipeline uses endogenous introns to normalize time course data and yields more reproducible half-lives than other methods, even with datasets that were otherwise unusable. DRUID can handle datasets from a variety of organisms, spanning yeast to humans, and we even applied it retroactively on published datasets. We anticipate that DRUID will allow broad application of metabolic labeling for studies of mRNA stability.
SUMMARY
Control of messenger RNA (mRNA) stability is an important aspect of gene regulation. The gold standard for measuring mRNA stability transcriptome-wide uses metabolic labeling, biochemical isolation of labeled RNA populations, and high-throughput sequencing. However, difficult normalization procedures and complex computational algorithms have inhibited widespread adoption of this approach. Here, we present DRUID (for Determination of Rates Using Intron Dynamics), a computational pipeline that is robust, easy to use, and freely available. Our pipeline uses endogenous introns to normalize time course data and yields more reproducible half-lives than other methods, even with datasets that were otherwise unusable. DRUID can handle datasets from a variety of organisms, spanning yeast to humans, and we even applied it retroactively on published datasets. We anticipate that DRUID will allow broad application of metabolic labeling for studies of mRNA stability.
INTRODUCTION
A critical component in controlling gene expression, RNA decay is essential for nearly all biological processes, from early development to inflammatory responses (Giraldez et al. 2006; Tadros et al. 2007; Brooks and Blackshear 2013) . However, transcriptome-wide measurements of mRNA half-lives have long been challenging and represent a major barrier for broad investigations of how mRNA stability is regulated. One strategy has been to shut off transcription, thereby repressing synthesis of all transcripts. In Saccharomyces cerevisiae, these experiments typically involve using a temperature-sensitive mutant of RNA polymerase II (Herrick et al. 1990; Grigull et al. 2004; Presnyak et al. 2015) , and work in mammalian cell lines has predominantly relied upon drugs that target RNA polymerases, such as actinomycin D and α-amanitin (Ross 1995; Bensaude 2011) . Each of these treatments places substantial stress on the cell and can alter the stability and localization of numerous transcripts, as well as broader phenotypes like cell growth (Bensaude 2011; Sun et al. 2013; Geisberg et al. 2014) .
Metabolic labeling has emerged as a powerful alternative strategy for determining RNA stabilities under more physiological conditions (Ross 1995; Rabani et al. 2011; Tani et al. 2012; Neymotin et al. 2014; Duffy et al. 2015) . This approach uses nucleobase or nucleoside analogs, such as 4-thiouridine (4SU), 5-bromouridine (BrU), or 5-ethynyl uridine (EU), all of which allow subsequent isolation of labeled RNA populations (Rabani et al. 2011; Tani et al. 2012; Imamachi et al. 2014; Neymotin et al. 2014; Duffy et al. 2015) . The selected RNA is then quantified, often by high-throughput sequencing.
Several experimental variations of metabolic-labeling methods have been described (Munchel et al. 2011; Tani et al. 2012; Imamachi et al. 2014; Neymotin et al. 2014) . One common method uses an approach-to-equilibrium strategy ( Figure 1A) . Here, cells are harvested after increasing times of incubation with the nucleoside analog. Over the time course, mRNA abundance of the labeled population approaches steady-state levels. Because the rate of this approach is determined by transcript stability, these measurements can be used to infer half-lives (Greenberg 1972; Ross 1995; Neymotin et al. 2014 ). However, the resultant data are complicated and not easily analyzed, unlike shut-off experiments whose results can be fit to simple exponential decay models. Thus, despite its clear benefits, the approach-to-equilibrium method remains inaccessible to the general researcher, and polymerase inhibitors remain much more broadly used (Burow et al. 2015; Kumagai et al. 2016; Mauer et al. 2016; Ayupe and Reis 2017) .
Here, we describe DRUID, a computational method for determining mRNA half-lives on a transcriptome-wide scale using metabolic labeling. By normalizing to intron-mapping reads, our method allowed us to determine mRNA stabilities with higher reproducibility and ease than other methods. DRUID can also rescue poorly behaving, and previously unusable, datasets, and can even be applied to datasets from species with few introns, such as S. cerevisiae. Finally, we have developed a computational package that is publically available to enable broader use by the community.
DESIGN

The conceptual underpinnings of metabolic labeling and approach-to-equilibrium kinetics
The approach-to-equilibrium strategy relies upon incorporation of a nucleotide analog into nascent transcripts so that, with increasing incubation periods, the fraction of transcripts labeled increases until steady-state has been reached. The RNA-seq readout of metabolic-labeling experiments can be envisioned as a series of pie-charts through time with each slice representing the relative proportion of reads mapping to each transcript ( Figure 1B) . Unlike most RNA-seq experiments, where only a handful of transcripts will change in abundance, during metabolic labeling experiments, the relative and absolute abundance of every transcript will change over the experiment ( Figure 1C ). For an individual transcript, its relative abundance is determined by synthesis and decay rates, but the absolute abundance of the total labeled population increases with longer exposure to the nucleotide analog at a rate sufficient to replace degraded, unlabeled RNA as well as to allow for cell growth ( Figure 1C , left panels). Determining mRNA half-lives requires taking both classes of behaviors into account.
The current solution uses exogenously added spike-ins to convert relative RNA-seq measurements into absolute measurements of RNA abundance ( Figure 1C , middle panels).
Typically, spike-ins are added to the harvested RNA from each time point prior to biochemical purification, and information about growth rate is necessarily lost at this step. Because the proportion of spike-ins to the total RNA sample remains constant, once the labeled population has been purified in vitro, the proportion of spike-ins decreases over time while that of the labeled sample increases. These ratios approach that in the original, unpurified sample ( Figure   1C , right panels). Individual transcripts will reach equilibrium with differing kinetics, determined entirely by their stability, with the most unstable transcripts reaching equilibrium the fastest. To calculate half-lives, the RNA-seq libraries are normalized to the spike-ins and further corrected for cell growth. A bounded growth equation is used to infer the decay rate of the unlabeled RNA population ( Figure 1D ).
Spike-ins are thus absolutely essential for determining half-lives using metabolic labeling. Although there are commercially available RNA-seq spike-ins (such as the ERCC set), these lack nucleotide analogs, such as 4SU, and so currently each laboratory in vitro transcribes their own standards, as needed (Imamachi et al. 2014; Neymotin et al. 2014) . However, there is no broadly accepted standard for these spike-ins, in terms of the number of transcripts, their nucleotide make-up, or length, and variations in spike-in make-up can have large effects on the eventual half-life determination. Indeed, previous attempts using three in vitro transcribed spikeins were associated with enough technical noise that biological replicates were combined in order to determine half-lives (Neymotin et al. 2014) .
DRUID: motivation and advantages
We initially identified two major barriers for the acceptance of the approach-to-equilibrium method: the cost, difficulty, and technical variation associated with current spike-ins; and the computational complexities for analyzing subsequent datasets. Our goal was to develop a method easy enough for widespread use of metabolic labeling, and so we set about reducing these barriers.
Because of the variability inherent in using a handful of in vitro transcribed spike-ins, we initially opted to use RNA from two organisms that differed from the species being interrogated.
For example, in experiments with HEK293 cells, we used 4SU-labeled RNA from Drosophila S2 cells (for normalization) and unlabeled S. cerevisiae RNA (to determine the enrichment obtained during the purification). These spike-ins were easy and cheap to generate, produced reproducible half-life measurements (see below), and were easily applied to mouse and human cell lines.
In the process of optimizing this method, we produced datasets that did not contain sufficient amounts of spike-ins for robust normalization. We asked whether normalization to some internal RNA species could salvage these datasets. Because introns are highly unstable, they reach equilibrium very quickly and can thus serve as a normalization factor. We thus developed DRUID, a robust method that normalizes to intron-mapping reads and calculates halflives. In contrast to other methods and our original design, DRUID can be applied retroactively to datasets not originally designed for this scheme. DRUID half-life measurements also show higher reproducibility than other methods, most likely because introns provide additional controls for a range of technical variables, such as 4SU-labeling efficiency and cell growth.
RESULTS
Normalizing to exogenous whole organism spike-ins allows for the calculation of RNA halflives
To determine mRNA half-lives in HEK293 cells, we initially used two sets of spike-ins: 4SUlabeled RNA from Drosophila S2 cells and unlabeled RNA from S. cerevisiae. The Drosophila and S. cerevisiae genomes differ sufficiently enough from the human one that even short reads can be unambiguously assigned ( Figure S1A ). We routinely observed 100-fold enrichment of 4SU-labeled Drosophila RNA compared to unlabeled yeast RNA, indicating that less than 1% of the signal in the selected population was due to nonspecific background (Figure 2A ). Subsequent analysis indicated that the S2 RNA was less labeled than the HEK293 RNA (Figure S1B, C), and so these enrichment values likely represent a lower bound.
As incubation with 4SU increased, samples showed reduced similarity in the abundance of human mRNAs ( Figure 2B ). Consistent with most transcripts having reached equilibrium by the last time point, the unpurified sample was least similar to the 1-hr sample and most similar to the 24 hr one (r s = 0.84 and r s = 0.98, respectively). In contrast, reads mapping to the Drosophila genomes were unaffected by different harvesting times ( Figure 2C ; r s = 0.92 to 0.97).
Longer 4SU-incubation times also resulted in a higher fraction of reads mapping to the human genome and a lower fraction to the Drosophila genome ( Figure 2D ). Although the behavior of individual transcripts from the S2-cell spike-in varied, the sum of all reads mapping to the Drosophila genome was resistant to outliers ( Figure 2E ). We normalized the humanmapping reads by the sum of Drosophila-mapping reads, fit a bounded-growth equation to the data, and corrected for the average doubling time in HEK293 cells. Unlike other approaches (Dölken et al. 2008 ), we did not rely upon the unselected sample for calculating half-lives, and thus our calculations were unaffected by differential selection biases (such as that reported for longer transcripts [Duffy et al. 2015] ).
We calculated half-lives for 12,890 genes in HEK293 cells ( Figure 2F ). There was wide variation in mRNA stability in these cells, with the most unstable transcript (ID1) having a halflife less than 15 minutes, and others having half-lives longer than the cell cycle. For these longlived transcripts, cell growth and dilution make a major contribution to their dynamics. The halflives were similar to those we generated with actinomycin D and α-amanitin (Figure S1E, F; r s = 0.65 and 0.62, respectively) and with those previously reported (r s = 0.62 [Tani et al. 2012] ).
These half-lives were generally reproducible ( Figure 2G ; r s = 0.61), although we noted that the longest-lived genes varied the most in magnitude (but not rank order) between replicates.
In these experiments, we had included six time points in addition to steady-state measurements. However, we hypothesized that not all of these time points would be necessary to determine stabilities, and using fewer samples could reduce the associated library preparation and sequencing costs. We repeated our analysis, but this time omitting individual time points.
With the exception of the 24 hr time point, the calculated half-lives were robust to the omission of a single time point ( Figure S1F ; r s = 0.95 to 1 vs. r s = 0.89). The 24-hr time point is likely critical for calculating half-lives, especially for more stable transcripts, because it represents near-equilibrium measurements. Surprisingly, using only three time points (1, 8, and 24 hr) gave similar measurements as with all the time points ( Figure 1H ; r s = 0.94). Although calculations become more robust with more time points, these three time points represent the minimum requirement for calculating half-lives in human cells using the approach-to-equilibrium method.
Internal short-lived RNA species can be used to determine mRNA stabilities
In the process of obtaining these half-life measurements, we generated flawed datasets that resulted from insufficient spike-in reads or inconsistent labeling bias, each of which gave a characteristic signature ( Figure S2A, B ). Such datasets would typically be excluded from downstream analysis, but we wondered if they could be rescued with alternative normalization methods. We hypothesized that because unstable endogenous RNA species quickly reach equilibrium, they could perform a role similar to that of the labeled spike-in RNA.
We noted that introns were especially abundant at the earliest time points, making up 19% of the total reads ( Figure 3A) . Moreover, as with the Drosophila spike-ins, the overall proportion of reads mapping to introns exhibited a time-dependent decrease ( Figure 3A) , and the relative abundance of individual introns did not show a large time-dependent decrease in similarity ( Figure S2C ; r s = 0.90 to 0.95), indicating that equilibrium levels were generally reached before the first time point. However, we noted that not all introns behave similarly ( Figure 3B ). While 1045 introns showed a time-dependent decrease in levels, 1564 introns, although expressed at sufficient levels, did not show evidence of being highly unstable.
Unexpectedly long-lived introns were likely included in the eventual mature transcript, either due to intron retention or alternative splicing (Braunschweig et al. 2014 ), or were misannotated.
We used the sum of all reads mapping to the well-behaved introns and calculated halflives for 12,673 genes in a pipeline we termed "DRUID". Unlike with exogenous spike-ins, DRUID does not require correction for cellular growth. These half-lives correlated with those obtained by normalizing to exogenous spike-ins ( Figure 3C ; r s = 0.99), although they were slightly shorter. Surprisingly, normalization to introns yielded half-lives even more reproducible than those we obtained earlier (r s = 0.77 vs. r s = 0.61). Moreover, the skew that we had observed between replicates for long-lived transcripts was not apparent when we used DRUID ( Figure 3D cf. Figure 2G ), indicating that DRUID gives reproducible rank order and magnitudes for mRNA half-lives. Intron normalization likely captures in vivo experimental variation better than the exogenous spike-ins, and is thus better-equipped to normalize for these differences. When we generated half-lives using only three time points (1, 8, and 24 hr), DRUID gave similar results ( Figure S2D ; r s = 0.92) and was reproducible between replicates (r s = 0.73). Together, our analyses indicate that reproducible half-lives can be obtained by normalizing to introns and using only three time points.
Orthologous mouse and human genes have similar mRNA half-lives
To further confirm the applicability of our method, we used DRUID to calculate mRNA halflives in NIH3T3 cells using well-behaving introns. We obtained measurements for 10,705 genes with high similarity between replicates ( Figure 3E ; r s = 0.77). As with our HEK293 experiments, DRUID performed better than using exogenous spike-ins for normalization ( Figure S2E ; r s = 0.70). These values were similar to those previously calculated ( Figure S2F ; r s = 0.66, [Schwanhäusser et al. 2011] ), although using our method we were able to determine half-lives for a much larger number of genes (5,029 vs. 10,705).
We next compared mRNA half-lives and equilibrium levels of orthologous human and mouse genes ( Figure 3F, Figure S2G) . Surprisingly, given that these two cell lines are from different organisms and derived from different cell types, we found a high correlation between RNA abundance and half-lives between mouse and human orthologs (r s = 0.57 and 0.63, respectively). Thus, although some transcripts, such as MBNL3, display striking differences in stability between HEK293 and NIH3T3 cells (26 hours vs. 36 minutes, respectively), many conserved transcripts are degraded at similar rates.
DRUID can retroactively rescue datasets
Having established that DRUID can be used on high quality datasets, we finally asked whether this normalization method could rescue previously unusable datasets. We focused on two datasets: one with too few spike-in reads and the other with abnormal spike-in behavior ( Figure   S2A, B) . For the first dataset, we were unable to calculate half-lives using the exogenous spikeins. For the second, we obtained half-lives for only 3987 genes. Although these measurements did correlate with other replicates (Figure 4A , r s = 0.51), we observed a strong skew for longlived transcripts.
Strikingly, for both datasets, intron normalization was able to overcome both types of technical difficulties, and we generated half-lives for over 10,000 genes. These half-lives correlated well with our other datasets ( Figure 4B , C; r s = 0.63-0.75). Importantly, we no longer observed the difference in half-life magnitude for stable transcripts that we saw with exogenous normalization ( Figure 4A vs. Figure 4B) . Thus, DRUID can be used for otherwise recalcitrant datasets.
One potential drawback of intron normalization is its applicability to organisms with few introns, such as S. cerevisiae. We thus applied DRUID to published datasets from budding yeast (Neymotin et al. 2014 ). When we calculated half-lives using the three exogenous spike-in transcripts, RNA half-lives were correlated ( Figure 4D ; r s = 0.58). However, DRUID generated half-lives that were better correlated ( Figure 4E ; r s = 0.72) and for a larger number of genes (3563 vs. 3981). We note that, irrespective of the computational scheme, the magnitude of halflives differed between these two replicates, suggesting that there may be additional technical issues, such as labeling bias, that are independent of normalization schemes. These results indicate that normalizing to introns can be used on datasets not designed for DRUID. Furthermore, DRUID is a robust and widely applicable normalization method, appropriate even for organisms with few introns.
DISCUSSION
Despite known and important issues in transcriptional shut-off approaches, RNA polymerase inhibitors remain in common use for determining transcript stability. To enable wider adoption of approach-to-equilibrium metabolic labeling strategies, we developed DRUID, a computational method that robustly calculates mRNA half-lives on a transcriptome-wide scale. Although we initially envisioned using exogenous spike-ins for a normalization approach, we were surprised that this framework was surpassed by intron normalization. DRUID was effective for all datasets we examined, irrespective of the organism examined, even those that were otherwise recalcitrant.
Our computational pipeline is publically available to enable wider use of the approach-toequilibrium strategy (see Methods).
Given the success of DRUID for calculating half-lives, is there any utility for including exogenous spike-ins? Although in principle they are not required, in practice, we still routinely include them in our experiments for two reasons. First, our exogenous spike-in strategy allows us to calculate the enrichment of labeled RNA in each dataset, thus confirming that the purification has worked as expected. Second, and more importantly, the exogenous spike-ins provide an independent normalization scheme and thus a useful quality control. Comparing between normalization schemes greatly increases confidence in the calculated half-lives and is particularly important when new cell types or systems are being used.
Limitations
As with all approach-to-equilibrium strategies (Greenberg 1972; Ross 1995) , there are two main requirements for DRUID. First, the labeling reagent, such as 4SU, must be readily taken up by the cell and incorporated into newly synthesized transcripts at concentrations that do not have negative physiological effects. Second, an underlying assumption of metabolic labeling and DRUID is that the system is at steady-state. Thus, in its current form, DRUID cannot be used to investigate scenarios where rates of synthesis and decay change throughout the experiment. Of course, biological processes, such as differentiation, are frequently defined by changes in both mRNA transcription and decay, and so an important next step is to generate experimental and computational methods that can monitor dynamic systems while remaining accessible to the broader community.
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Figure 1. Conceptual underpinnings of the approach-to-equilibrium method.
(A) Representation of the approach-to-equilibrium experimental method. Cells are incubated with 4SU for increasing amounts of time. Isolated RNA is then biotinylated in vitro and purified using streptavidin. The eluate is then prepared for high-throughput RNA sequencing. (C) Simulation of abundances during an approach-to-equilibrium experiment for the transcriptome (top) and individual transcripts (bottom). Left: As cells are incubated longer with 4SU, the labeled RNA population increases at a rate sufficient to replace the unlabeled population and for cell growth. The unlabeled population for unstable transcripts (pink) necessarily decreases faster than for stable transcripts (blue). Center: Once the RNA is extracted, spike-ins are added at a constant ratio to the total amount of RNA, and information about cell growth is lost. Right: After purification, the ratio of spike-in to labeled sample behaves stereotypically with a rapid decrease over the initial time points and convergence to an asymptote, which represents the ratio of the RNAs in the unpurified sample. Note that at early time points, unstable transcripts represent a larger fraction of the library than their eventual steady-state ratios.
(D) Simulation of normalization strategies. The pie charts (from (B)) are normalized to spike-in levels to calculate the relative abundance of the entire transcriptome or specific transcripts, as appropriate. These measurements can then be growth-corrected, and, using a bounded growth equation, half-lives can be calculated. Note that correcting for growth has a larger effect on stable transcripts than on unstable ones. Transcription shut-off experiments. HEK293 cells were treated with either 5 µg/mL actinomycin D or 50 µg/mL α-amanitin for 0, 1, 2, 4, 8, 12, and 24 hr and were harvested as described above.
In vitro biotinylation and biotin-streptavidin pull down. A 1 mg/mL solution of HPDP-biotin (Thermo Fisher Scientific) in dimethylformamide was incubated at 37°C for 30 min. 40-100 µg of RNA was combined with 20% w/w unlabeled yeast RNA and 20% w/w 4SU labeled fly RNA (human RNA for fly samples) and 120 µL of 2.5x citrate buffer (25 mM citrate pH 4.5, 2.5 mM EDTA) in a total volume of 240 µL. Sixty microliters of HPDP-biotin solution was added, and the RNA was incubated for 2 hr at 37°C, covered and shaking at 300 rpm. RNA was then phenol-chloroform extracted and ethanol precipitated with 2 µL of glycoblue (Life Technologies). The RNA pellet was resuspended in 200 µL of 1x wash buffer (10 mM Tris-Cl pH 7.4, 50 mM NaCl, 1 mM EDTA).
Fifty microliters of MACS microbeads (Miltenyi Biotec) were incubated with 48 µL of 1x wash buffer and 2 µL of yeast tRNA for 20 min at room temperature with rotation.
METHODS
MACS microcolumns (Miltenyi Biotec) were washed with 100 µL of nucleic acid equilibration buffer (Miltenyi Biotec) and then five times with 100 µL of 1x wash buffer.
Beads were applied to the column in 100 µL aliquots and washed five times with 100 µL of 1x wash buffer. Columns were demagnetized and beads eluted with two 100 µL washes with 1x wash buffer, and columns were remagnetized. The 200 µL bead solution was combined with RNA sample and rotated at room temperature for 20 min. The sample was then applied to the column in 100 µL aliquots. Columns were washed three times with 400 µL of wash 1 buffer (10 mM Tris-Cl pH 7.4, 6 M urea, 10 mM EDTA) prewarmed to 65°C and then three times with 400 µL wash 2 buffer (10 mM Tris-Cl pH 7.4, 1 M NaCl, 10 mM EDTA). RNA bound to the column was eluted with five washes of 1x wash buffer with 0.1 M dithiothreitol, and then ethanol precipitated with 2 µL of glycoblue.
RNA sequencing. Sequencing libraries were prepared using the TruSeq Stranded mRNA Sample preparation kit (Illumina), according to manufacturer's instruction manual (Rev. E), and sequenced at The Centre for Applied Genomics (SickKids).
Computational analysis: read mapping. Libraries were pooled and sequenced on an Illumina HiSeq 2500 to give 50 bp single-end reads. RTA v1.18.54 or later was used for base calling and quality scores, bcl2fastq2 v2.17 or later was used to demultiplex samples and to convert reads to fastq format. Library quality was assessed using FastQC v0.11.5
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Reads were trimmed and clipped for Illumina adaptors using Trimmomatic v0.36 (Bolger et al. 2014 ) with the following options LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15 MINLEN:36.
Reads were aligned to merged reference genomes (hg38 + sacCer3, hg38 + dm6 +
